Financing type:  underwritten prospectus offering

Gross proceeds:   $86,526,000

Offering:  26.22 million listed shares

Offering price:  $3.30 per listed share

Overallotment option:  The underwriters may purchase a maximum of 3.42 million listed shares for overallotment purposes. As of Oct. 1, 2025, such option has been exercised in full. All information presented herein includes such exercise.

Public disclosure:  refer to the prospectus supplement dated Sept. 26, 2025, and the company's news release(s) dated Sept. 24, 2025, Sept. 25, 2025, and Oct. 1, 2025